Siegfried Holding AG SFZN

Morningstar Rating
CHF 70.00 0.00 (0.00%)
View Full Chart

Company Report

Narrow-Moat Siegfried's Strong Demand and Expanded US Capacity Support Long-Term Growth

Siegfried is a leading global contract development and manufacturing organization. It was founded in 1873 as the first pharmacy wholesaler and has reinvented itself several times since, evolving into a global player with advanced manufacturing facilities and lengthy customer relationships. Siegfried's growth over the last 14 years has allowed it to become a leading CDMO. Since 2010, sales have quadrupled, and the workforce has grown fivefold. The company has expanded from three manufacturing sites to 16 across four continents, and this scale has allowed it to further develop its contract manufacturing business.

Price vs Fair Value

SFZN is trading at a LOCK|?&c!!@$ premium.
Price
CHF 70.00
Fair Value
!g!
Uncertainty
LOCK|wry!Z
1-Star Price
LOCK|c.f?
5-Star Price
LOCK|.n
Economic Moat
LOCK|H@!t
Capital Allocation
LOCK|?##>%v

Bulls Say, Bears Say

Bulls

As drug manufacturing becomes more complex, the long-term outlook appears bright as biotechnology and pharmaceutical firms will be more reliant on outsourced manufacturing.

Bears

Siegfried is vulnerable to facility closures, whether from natural disasters or manufacturing issues. A warning letter from the FDA or another regulatory agency can result in manufacturing delays or closures.

Trading Information

Previous Close Price
CHF 70.00
Day Range
CHF 69.85–70.60
52-Week Range
CHF 65.05–101.60
Bid/Ask
CHF 70.00 / CHF 70.10
Shares Outstanding
43.81M
Market Cap
CHF 3.07B
Volume/Avg
34,846 / 105,593

Key Statistics

Price/Earnings (Normalized)
17.88
Price/Sales
2.27
Dividend Yield (Trailing)
0.57%
Dividend Yield (Forward)
0.57%
Dividend Payment Schedule
Apr
Total Yield
0.81%

Company Profile

Siegfried is a global contract development and manufacturing organization. It derives its revenue primarily from long-term supply agreements with biotechnology and pharmaceutical customers. Siegfried develops and manufactures active pharmaceutical ingredients, finished dosage forms (tablets, capsules, sterile vials, ampules, cartridges, and ointments), and viral vectors. The company provides these services throughout the entire drug lifecycle, including chemical and analytical development, pilot manufacturing, and commercial-scale manufacturing. Siegfried has a large global footprint with 16 production sites on four continents.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Mid Core
Total Number of Employees
4,454

Competitors

Valuation

Metric
SFZN
LONN
02269
Price/Earnings (Normalized)
17.8835.8031.58
Price/Book Value
3.075.043.86
Price/Sales
2.276.497.87
Price/Cash Flow
12.8420.9221.36
Price/Earnings
SFZN
LONN
02269

Financial Strength

Metric
SFZN
LONN
02269
Quick Ratio
1.360.592.64
Current Ratio
3.451.663.32
Interest Coverage
24.559.2967.52
Quick Ratio
SFZN
LONN
02269

Profitability

Metric
SFZN
LONN
02269
Return on Assets (Normalized)
7.56%6.27%10.38%
Return on Equity (Normalized)
15.73%13.97%14.65%
Return on Invested Capital (Normalized)
10.10%9.75%11.25%
Return on Assets
SFZN
LONN
02269

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|SFLlZwY^LOCK|>SQ#>$70B
Teva Pharmaceutical Industries Ltd
TEVA
LOCK|yg%%x&?SLOCK|K?p>$49B
Haleon PLC ADR
HLN
LOCK|>KWnlhLOCK|R!$44B
Zoetis Inc Class A
ZTS
LOCK|@q@^g%PLOCK|g!&$32B
Viatris Inc
VTRS
LOCK|$NPRF!LOCK|n#$21B
Elanco Animal Health Inc
ELAN
LOCK|Y%CLOCK|cx$12B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|gg>#G?>LOCK|&^$11B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|@vh@pdhLOCK|KcF$7B
Prestige Consumer Healthcare Inc
PBH
LOCK|p%MKT%#LOCK|#&mn!$2B
Perrigo Co PLC
PRGO
LOCK|&Np%S&LOCK|Lg$2B

Sponsor Center